Fig. 3
From: PACAP38-induced migraine attacks are independent of CGRP signaling: a randomized controlled trial
Vascular parameters. Comparison of mean change in facial skin blood flow and mean change in superficial temporal artery diameter between placebo-PACAP-38 (blue) and eptinezumab-PACAP-38 (red) interventions.